Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Pharmacies can help extend access to PrEP among MSM, says study
Access to pre-exposure prophylaxis (PrEP) may be expanded through pharmacies to reach racial minorities of men who have sex with men (MSM) with the highest need but are not being reached, suggest the results of a US study.
Pharmacies can help extend access to PrEP among MSM, says study
19 Oct 2021
Which NSAID is most effective for osteoarthritis?
The most effective nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and function in patients with osteoarthritis (OA) are etoricoxib 60 mg/day and diclofenac 150 mg/day, suggests a study. However, these medications may not be suitable for those with comorbidities or for long-term use due to the slight increase in the risk of adverse events.
Which NSAID is most effective for osteoarthritis?
19 Oct 2021
DOACs on par with LMWH at preventing VTE in cancer patients
Cancer patients receiving either low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) show comparable frequency of venous thromboembolism (VTE), reports a recent study.
DOACs on par with LMWH at preventing VTE in cancer patients
19 Oct 2021
Tezepelumab improves lung function in severe asthma
In the treatment of patients with severe, uncontrolled asthma, use of tezepelumab appears to produce rapid and sustained improvements in lung function, as reported in a study.
Tezepelumab improves lung function in severe asthma
19 Oct 2021
3-day remdesivir prevents hospitalization, death in COVID-19
A 3-day course of remdesivir may help stave off COVID-19–related hospitalization and death, according to results of the phase III PINETREE study.
3-day remdesivir prevents hospitalization, death in COVID-19
18 Oct 2021
Drug-delivery device implant works well for neovascular AMD
An ocular implant that continuously dispenses an antivascular endothelial growth factor (anti-VEGF) therapy into the vitreous performs well in the management of neovascular age-related macular degeneration, affording disease control and achieving vision and anatomical outcomes similar to that obtained with monthly intravitreal injections, as shown in the phase III ARCHWAY trial.
Drug-delivery device implant works well for neovascular AMD
18 Oct 2021
Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients
The combination of aspirin and warfarin therapy appears to increase the risk of bleeding, with little benefit in reducing stroke or cardiovascular events compared with warfarin alone in patients with atrial fibrillation (AF), reveals a study.